REFLOCIBART

UNII:	67AB88J6KN
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	REFLOCIBART
GSRS Full Record:	67AB88J6KN i

2642578-92-3
CSL-346
CSL346
Gamma4 heavy chain humanized(1-447) [VH (Homo sapiens IGHV1-2*06 (88.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120)-Homo sapiens IGHG4*01,nG4m(a) CH2 L92, G4v5 h P10 (CH1 (121-218), hinge 1-12 S10>P (228) (219-230), CH2 L92 (309) (231-340), CH3 (341-445),CHS (446-447)) (121-447)], (134-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-39*01 (88.4%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153'), V101 (191') (108'-214')]; dimer (226-226'':229-229'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells
Immunoglobulin G4 [228-proline], anti-(human vascular endothelial growth factor B) (human-Mus musculus monoclonal CSL346 γ4-chain), disulfide with human-Mus musculus monoclonal CSL346 κ-chain, dimer
Immunoglobulin G4-kappa, anti-[Homo sapiens VEGFB (vascular endothelial growth factor B)], humanized monoclonal antibody
Reflocibart
reflocibart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

REFLOCIBART

Synonyms and Mappings

Resources